Skip to Content

LCE 50 (Carbidopa, Entacapone and Levodopa 12.5 mg / 200 mg / 50 mg)

Pill with imprint LCE 50 is Brown, Round and has been identified as Carbidopa, Entacapone and Levodopa 12.5 mg / 200 mg / 50 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 50

Carbidopa, Entacapone and Levodopa

Imprint
LCE 50
Strength
12.5 mg / 200 mg / 50 mg
Color
Brown
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc

Labelers / Repackagers

NDC CodeLabeler / Repackager
00781-5613 Sandoz Inc.
00078-0407 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Related Images for "LCE 50"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.